Hội nghị Dược lâm sàng online 2017 – Thông báo số 2

ABSTRACT INFORMATION

The conference invites contributions on the following topics :

• Clinical Pharmacy
• Social and Administrative Pharmacy
• Pharmacy Education
• Pharmacoeconomics
• Pharmacoepidemiology
• Complementary and Alternative Medicine (CAM)
• Other topics in pharmacy

Instruction for Abstract Preparation (please see the example):

• The abstract should be written in English and should not contain references or footnotes. None abbreviation are allowed in abstract, both in title and abstract body. The abstract is structured as follows:
  • Title of abstract:
    • Abbreviation must not be used in the title
    • First letter of the first word in the title sentence must be written in CAPITAL letter.
  • Name and affiliation of authors

The name of each author must include the first given name, followed by the last name.  No titles (MS, PhD, PharmD, etc) should be added. If authors are from different institutions, please use number typed in superscript for each institution and author accordingly. The contact address and email for the corresponding author must also be provided.

• Abstract body (maximum 250 words).The organization of abstract body should be covered:
• Background
• Objective(s)
• Method(s)
• Result(s)
• Conclusion
• Keywords of research (maximum 5 words), in alphabetical order below the abstract.

Example:

Telehealth for optimizing asthma management during pregnancy: a randomized controlled trial

Elida Zairina¹, Michael J Abramson², Kay Stewart³, Johnson George³

¹Dept of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia

²Dept of Epidemiology, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

³Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia

Corresponding author:

Elida Zairina

Dept of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.

Email: elida-z@ff.unair.ac.id

Background:

Managing asthma in pregnant women is an integral part of asthma guidelines; however poorly controlled asthma during pregnancy still remains a major problem.

Objective:

This study aimed to evaluate the efficacy of a telehealth program supported by a handheld respiratory device in improving asthma control during pregnancy.

Methods:

Pregnant women with asthma (n=72) from two antenatal clinics in Melbourne, Australia were randomized to one of the two groups: 1) intervention – involving a telehealth program and written asthma action plan supported by a handheld respiratory device and a smart phone application (Breathe-easy^©); or 2) control group – usual care. Both groups were followed prospectively and their asthma control scores were compared at 3 and 6 months

Results:

At baseline, participants’ mean (±SD) age was 31.4±4.5 years and gestational age 16.7±3.1 weeks. No significant differences in demographic, maternal or clinical characteristics were observed. At 6 months, compared to the usual care group, the MASTERY group had better asthma control (p=0.02) and asthma-related quality of life (p<0.01). There were no significant differences between groups in lung function, unscheduled healthcare visits, days off work/study, oral corticosteroid use or perinatal outcomes. No significant differences between groups were found at 3 months.

Conclusion:

Telehealth interventions supporting self-management are feasible and efficacious to improve asthma control and asthma-related quality of life during pregnancy.

Keywords: asthma, pregnant women, telehealth

Sau đó, dịch Abstract trên sang tiếng Việt. Gửi cả Abstract tiếng Anh + tiếng Việt.